Marker Therapeutics, Inc. 10-Q, filed May 21, 2012: IDEA: XBRL DOCUMENT
|
RELATED PARTY TRANSACTIONS
|
3 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Mar. 31, 2012
|
||||||||||
| RELATED PARTY TRANSACTIONS | Note 8: Related Party Transactions
During the three months ended March 31, 2012, the Company entered into transactions with certain officers and directors of the Company as follows:
All related party transactions (other than stock based consideration) involving provision of services were recorded at the exchange amount, which is the amount established and agreed to by the related parties as representing fair value. The Company accounted for the debt settlement transactions with related parties at management’s estimate of fair value, using amounts similar to arm’s length settlements for debt settled.
At March 31, 2012, the Company had amounts owing to directors and officers of $293,805 (December 31, 2011 - $322,905). Amounts due to related parties are unsecured, non-interest bearing and have no specific terms of repayment. |